OMDA
$24.04
$-0.26 (-1.07%)-1.07%
After HoursLoading chart...
IndexN/A
Market Cap1.43B
Enterprise Value0.70B
Income$-0.01B
Sales$0.05B
EmployeesN/A
P/E343.43
P/S3.54
P/B4.01
P/C54.46
EV/EBITDA-147.27
EV/SalesN/A
EPS (ttm)0.07
EarningsN/A
Gross Margin65.69%
Oper. Margin-4.60%
Profit Margin-4.91%
Volume0.95M
Shs Outstand0.06B
Change-1.35%
Dividend Est.N/A
Dividend Ex-DateN/A
Perf YTDN/A
Perf YearN/A
Perf 3YN/A
Perf 5YN/A
Perf 10YN/A
IPON/A
| Metric | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Revenue | $169.80M | $122.78M | $89.19M |
| Cost of Revenue | $66.92M | $52.81M | $46.39M |
| Gross Profit | $102.88M | $69.97M | $42.79M |
| Gross Margin | 60.59% | 56.99% | 47.98% |
| Operating Expenses | $146.53M | $135.97M | $115.14M |
| Operating Income | $-43.65M | $-66.00M | $-72.35M |
| Operating Margin | -25.71% | -53.75% | -81.12% |
| Net Income | $-47.14M | $-67.51M | $-72.52M |
| Net Margin | -27.76% | -54.98% | -81.31% |
| EPS (Basic) | $-0.85 | $-1.21 | $-1.30 |
| EBITDA | N/A | N/A | N/A |
| Stock Option Compensation Expense | N/A | N/A | N/A |
| Price To Earnings Ratio | N/A | N/A | N/A |
| Price To Sales Ratio | N/A | N/A | N/A |
| Shares Outstanding | N/A | N/A | N/A |
| Market Capitalization | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Cash & Short Term Investments | N/A | N/A | N/A |
| Short Term Receivables | N/A | N/A | N/A |
| Inventories | N/A | N/A | N/A |
| Other Current Assets | N/A | N/A | N/A |
| Total Current Assets | N/A | N/A | N/A |
| Net Property, Plant & Equipment | N/A | N/A | N/A |
| Total Investments and Advances | N/A | N/A | N/A |
| Long-Term Note Receivable | N/A | N/A | N/A |
| Intangible Assets | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A |
| Other Assets | N/A | N/A | N/A |
| Total Assets | $150.89M | $175.08M | $221.80M |
| Short Term Debt Incl. Current Port. of LT Debt | N/A | N/A | N/A |
| Accounts Payable | N/A | N/A | N/A |
| Income Tax Payable | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A |
| Total Current Liabilities | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A |
| Provision for Risks Charges | N/A | N/A | N/A |
| Deferred Tax Liabilities | N/A | N/A | N/A |
| Other Liabilities | N/A | N/A | N/A |
| Total Liabilities | $86.26M | $76.16M | $66.19M |
| Non-Equity Reserves | N/A | N/A | N/A |
| Preferred Stock - Carrying Value | N/A | N/A | N/A |
| Common Equity | N/A | N/A | N/A |
| Total Shareholders Equity | $64.63M | $98.92M | $155.60M |
| Accumulated Minority Interest | N/A | N/A | N/A |
| Total Equity | $64.63M | $98.92M | $155.60M |
| Total Liabilities & Stockholders Equity | $150.89M | $175.08M | $221.80M |
| Book Value Per Share | N/A | N/A | N/A |
| Tangible Book Value Per Share | N/A | N/A | N/A |
| Full-Time Employees | N/A | N/A | N/A |
| Price to Book Ratio | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A |
| Return on Invested Capital | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A |
| Metric | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Net Income | $-47.14M | $-67.51M | $-72.52M |
| Depreciation | N/A | N/A | N/A |
| Other Funds (Non Cash) | N/A | N/A | N/A |
| Funds from Operations | N/A | N/A | N/A |
| Extraordinary Item | N/A | N/A | N/A |
| Changes in Working Capital | N/A | N/A | N/A |
| Income Taxes Payable | N/A | N/A | N/A |
| Cash from Operating Activities | $-34.18M | $-49.74M | $-68.98M |
| Capital Expenditures | N/A | N/A | N/A |
| Net Assets From Acquisitions | N/A | N/A | N/A |
| Sale of Fixed Assets and Businesses | N/A | N/A | N/A |
| Purchase or Sale of Investments | N/A | N/A | N/A |
| Purchase of Investments | N/A | N/A | N/A |
| Sale Or Maturity of Investments | N/A | N/A | N/A |
| Other Uses | N/A | N/A | N/A |
| Other Sources | N/A | N/A | N/A |
| Cash from Investing Activities | N/A | N/A | N/A |
| Cash Dividends Paid | N/A | N/A | N/A |
| Change in Capital Stock | N/A | N/A | N/A |
| Repurchase of Common Pref Stock | N/A | N/A | N/A |
| Sale of Common Pref Stock | N/A | N/A | N/A |
| Proceeds from Stock Options | N/A | N/A | N/A |
| Issuance or Reduction of Debt, Net | N/A | N/A | N/A |
| Change in Long Term Debt | N/A | N/A | N/A |
| Issuance of Long Term Debt | N/A | N/A | N/A |
| Reduction of Long Term Debt | N/A | N/A | N/A |
| Net Financing Active Other Cash Flow | N/A | N/A | N/A |
| Other Financing Activities Uses | N/A | N/A | N/A |
| Cash from Financing Activities | N/A | N/A | N/A |
| Exchange Rate Effect | N/A | N/A | N/A |
| Net Change in Cash | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A |
| Preferred Dividends (Cash Flow) | N/A | N/A | N/A |
| Price to Free Cash Flow | N/A | N/A | N/A |
Company coverage
Latest news
Omada Health to Participate in Canaccord Genuity’s 46th Annual Growth ConferenceGlobeNewswire Inc. Omada Health CEO Sean Duffy Sells 17,000 Shares. What Does This Mean for Investors?The Motley Fool Digital Health for the Musculoskeletal Care Market: 2026-2032 Outlook | Increasing Investment in Health and Fitness Apps Drives Adoption of Digital Health Solutions for Musculoskeletal Health TrackingGlobeNewswire Inc. Oceaneering Stock Is Up 105% in a Year, and One Fund Just Disclosed a $7 Million Bet on More GrowthThe Motley Fool Voyager Stock Up 12% Post-IPO as One Fund Commits Nearly 30% of AssetsThe Motley Fool Digital Health Coaching Market Size Worth $28.40 Billion by 2032, Drive by AI-Driven Personalization and Rising Demand for Preventive Care – SNS InsiderGlobeNewswire Inc. Omada Health to Present Real-World Evidence at ObesityWeek 2025 Demonstrating Enhanced Outcomes for Current and Former GLP-1 UsersGlobeNewswire Inc. Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie CountingGlobeNewswire Inc.
Insider Trading
View AllInsider
Type
Shares
Price
Value
Date
Company
About the company
Omada Health is an American virtual health company that delivers evidence-based digital programs designed to manage common chronic ailments, including cardiometabolic, musculoskeletal, and behavioral health conditions, offering continuous support that bridges the gap between in-person medical appointments.
Discover more
You may be interested in